Literature DB >> 12757775

Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease.

A D Blann1, J Constans, P Carpentier, M Renard, B Satger, V Guérin, M R Boisseau, N Neau-Cransac, C Conri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12757775     DOI： 10.1016/s0049-3848(03)00209-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis.

Authors:  Shervin Assassi; Minghua Wu; Filemon K Tan; Jeffrey Chang; Tiffany A Graham; Daniel E Furst; Dinesh Khanna; Julio Charles; Emma C Ferguson; Carol Feghali-Bostwick; Maureen D Mayes
Journal:  Arthritis Rheum       Date:  2013-11

2.  Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  F Iannone; M T Riccardi; S Guiducci; R Bizzoca; M Cinelli; M Matucci-Cerinic; G Lapadula
Journal:  Ann Rheum Dis       Date:  2007-11-20       Impact factor: 19.103

3.  Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.

Authors:  Line V Iversen; Susanne Ullman; Ole Østergaard; Christoffer T Nielsen; Poul Halberg; Tonny Karlsmark; Niels H H Heegaard; Søren Jacobsen
Journal:  BMC Musculoskelet Disord       Date:  2015-08-12       Impact factor: 2.362

4.  Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.

Authors:  Minoru Hasegawa; Yoshihide Asano; Hirahito Endo; Manabu Fujimoto; Daisuke Goto; Hironobu Ihn; Katsumi Inoue; Osamu Ishikawa; Yasushi Kawaguchi; Masataka Kuwana; Fumihide Ogawa; Hiroki Takahashi; Sumiaki Tanaka; Shinichi Sato; Kazuhiko Takehara
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.